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1. Introduction 
Adenylate cyclases are supramolecular structures 
resulting from the association of several components: 
a catalytic subunit, a receptor for hormones or neuro- 
transmitters, a guanine-nucleotide binding protein 
and, possibly, one or several additional subunits such 
as a coupling or transducing factor [l-6]. How the 
different components of the system interact is still 
largely unknown, although it has been suggested that 
the size of the adenylate cyclase complex increases 
with increasing complexity of regulation [7]. Cross- 
linking agents [8-lo] might be useful tools to inves- 
tigate these interactions, as recently done with the 
insulin-responsive glucose transport system in adipo- 
cytes [ 1 I]. Among the crosslinking agents, two simple 
aldehydes, formaldehyde and glutaraldehyde, have 
been widely used for fixation of tissues as well as for 
the study of subunits interactions in proteins [12-l 81. 
The effects of these aldehydes on the adenylate 
cyclase activity of rat cerebellar synaptosomes are 
reported here. The exposure to these crosslinking 
agents is shown to alter the regulation of the parti- 
culate and soluble enzyme by GTP and by its non- 
hydrolysable analog guanylylimidodiphosphate 
(Gpp(NH)p), by NaF and by EGTA, but not by Ca2+ 
or adenosine and its analogs. Another interesting 
effect of aldehyde-treatment of membrane-bound 
adenylate cyclase is that it not only preserves the 
activated state of the particulate enzyme after expo- 
sure to NaF or Gpp(NH)p, but it also allows the 
maintenance of this activated state throughout solu- 
bilization. A preliminary account of this work has 
been presented [19]. 
2. Materials and methods 
2.1. Preparation of synaptosomes 
Cerebella from 3 week old Sprague-Dawley (male 
ElsevierlNorth-Holland Biomedical Press 
or female) rats were homogenized in an ice-cold solu- 
tion (STM) containing 50 mM Tris-HCl (pH 7.3), 
5 mM MgC12, 10% (w/v) sucrose and protease inhi- 
bitors, using a Potter glass-Teflon homogenizer 
(size B) and 4 strokes at 1500 rev./min. A 30% Ficoll 
solution in STM was then added to the homogenate 
so as to adjust it at a refractive index of 29% as 
measured in a Bleecker refractometer. This homog- 
enate, overlayered by a sucrose-Ficoll solution of 
refractive index 22Y0, was centrifuged in a Spinco 
SW 27 rotor at 130 000 X g for 3 h. The synapto- 
somes floated at the interface between the 2 Ficoll- 
sucrose solutions (to be described elsewhere). This 
fraction was pelleted (100 000 X g, 20 min, 4°C) 
and the pellet washed in an ice-cold solution con- 
taining 50 mM sodium cacodylate (pH 7.3) and 
10% sucrose (CS buffer) (1 mg protein/ml). 
2.2. Treatment of synaptosomes 
The pellets of washed synaptosomes were resus- 
pended in CS buffer and incubated for 10 min at 20°C 
with or without glutaraldehyde or formaldehyde, at 
concentrations given in the text or legends. These 
fractions were then diluted 6-fold with cold CS buffer, 
pelleted, and washed in cold CS buffer. The pellets 
were resuspended in 50 mM Tris-HCl buffer (pH 8.1) 
and used at once or kept frozen. They were given the 
symbol ‘A’ for fractions treated by aldehydes, ‘U’ for 
untreated fractions. 
In some cases, the synaptosomes (starting material) 
were incubated at 30°C for 30 min in CS buffer 
without addition, or with either 20 mM NaF, 0.1 mM 
Gpp(NH)p or 1 mM adenosine or 2’-deoxyadenosine. 
The fractions were then divided into 2 aliquots, one 
of which was treated for 10 min at 20°C with gluta- 
raldehyde or formaldehyde as above. 
2.3. Adenylate cyclase assay 
Adenylate cyclase was assayed at 36°C or 30°C as 
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in [20]. Cyclic [“‘PI AMP was measured according to 
[21]. The adenylate cyclase activity was strictly pro- 
portional to the amount of proteins added and 
remained stable for at least 6 min. 
2.4. Solubilization of synaptosomes 
Suspensions of synaptosomes in a 50 mM Tris-HCl 
(pH 8.1) buffer containing 2 mM DTT and 0.75% 
Lubrol-PX (Lubrol:protein ratio (w/w) 27) were 
homogenized by hand at 20°C using a Potter glass- 
Teflon homogenizer and 3-4 strokes. The suspensions 
were centrifuged at 40 000 X g for 10 min, 4°C. Super- 
natants and resuspended pellets were tested for ade- 
nylate cyclase activity at 30°C. Proteins were deter- 
mined according to [22]. 
2 5. Source of materials 
[Q-~~P]ATP (0.5-10 Ci/mmol) and c[jH]AMP 
(20 Ci/mmol) were from Amersham. Glutaraldehyde, 
stored frozen, was from Sigma. Formaldehyde solu- 
tions were freshly prepared from Merck paraformal- 
dehyde by dissolving at 80°C. Nucleotides and analogs 
were from Sigma. All chemicals were reagent-grade. 
3. Results 
3.1. Persistance of adenylate cyclase activity in alde- 
hyde-treated synaptosomes 
Treatment of cerebellar synaptosomes by low con- 
centrations of formaldehyde or glutaraldehyde caused 
a significant increase in adenylate cyclase activity. This 
increase reached as much as 130% and 150% of the 
control value with, respectively, 0.5 mM glutaralde- 
hyde and 15 mM formaldehyde (fig.1). At higher 
aldehyde concentrations (>l mM glutaraldehyde, 
30 mM formaldehyde) a progressive decrease of ade- 
nylate cyclase activity took place. 
3.2. Loss of regulation of adenylate cyclase by GTP, 
NaF and EGTA, after aldehyde treatment 
Incubation of untreated synaptosomes with 
Gpp(NH)p or NaF resulted as expected [23,24] in a 
1.553-fold increase in adenylate cyclase activity; 
with 50 /IM GTP, the stimulation was 1.3-l S-fold. 
On the other hand, after treatment of the synapto- 
somes by aldehydes the regulation of adenylate cyclase 
by these effecters was lost (fig.2). Incubation of alde- 
hyde-treated synaptosomes with NaF or Gpp(NH)p 
caused a slight but reproducible decrease (20-40%) 
in adenylate cyclase activity. 
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Fig. 1. Aliquots of cerebellar synaptosomes were incubated for 
10 mm at 30°C in 50 mM cacodylate buffer (pH 7.4) and 
glutaraldehyde or formaldehyde at varying concentrations. 
They were diluted in cold buffer and pelleted. The pellets 
were resuspended in 50 mM Tris-HCI (pH 8.1) buffer, and 
tested for adenylate cyclase activity. The enzyme activity 
contained in untreated synaptosomes was taken as 100%. 
(-e-e-) Synaptosomes incubated in glutaraldehyde; 
(-fl- - - - -e-) synaptosomes incubated in formaldehyde. 
J;ig.2. Aliquots of untreated (-) and 0.5 mM glutaralde- 
hyde-treated (- - - - -) synaptosomes were incubated for 
20 min at 36°C in adenylate cyclase assay medium (pH 8.1, 
5 mM Mg*‘) without [‘*PI ATP, in the presence of varying 
concentrations of NaF (=, 0) or Gpp(NH)p (0, 0). [32P]ATP 
was then added, and adenylate cyclase activity assayed over 
10 min. (The dose-response curve of particulate adenylate 
cyclase with respect to Gpp(NH)p appeared spread over 
several orders of magnitude of nucleotide concentration, 
and of rather low amplitude. This was probably due to the 
existence of an intrasynaptosomal pool of GTP). 
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Fig.3. Aliquots of untreated (-•-ep), 0.2 mM glutamlde- 
hyde-treated (-e- - - -a-) and 2 mM glutaraldehyde-treated 
(o- - - -0) cerebellar synaptosomes (a) and their corresponding 
Lubrol supernatants (b) were assayed for adenylate cyclase in 
the presence of 5 mM Mg*+, and varying concentrations of 
EGTA. Assay conducted at 36°C for synaptosomes, 30°C for 
supernatants. 
Similarly, the inhibitory effect of ECTA on ade- 
nylate cyclase occurring in the presence of Mg” was 
lost as a result of aldehyde treatment. However this 
loss of enzyme regulation by EGTA occurred only 
at >O.S mM glutaraldehyde (fig.3a). By contrast, 
abolition of activation by NaF and Gpp(NH)p was 
obtained with much lower (0.05 mM) glutaraldehyde 
concentrations. Adenylate cyclase was not inhibited 
by EGTA in the presence of Mn2’ in untreated or 
aldehyde-treated fractions. 
3.3. Persistance of the inhibitory effects of Ca2’, 
adenosine and its analogs on adenylate cyclase 
after aldehyde treatment 
In the presence of Mg2+, the adenylate cyclase 
from both untreated and aldehyde-treated synapto- 
somes were inhibited by Ca? (table 1). Increasing 
Ca2+ from 0.05-l mM caused a 90% inhibition of the 
adenylate cyclase activity in both cases. The enzymes 
from both sources were not inhibited by Ca2+ if Mn2+ 
was present. 
Adenosine and some of its analogs modified in the 
ribose ring (2’-deoxyadenosine, 3’-deoxyadenosine) 
inhibited adenylate cyclase activity in aldehyde-treated 
and untreated synaptosomes in an identical manner at 
all concentrations tested (table 1). 
3.4. Solubilization of adenylate cyclase from aldehyde- 
treated synaptosomes 
3.4.1. Extent of solubilization 
Exposure of untreated synaptosomes to 0.75% 
Lubrol resulted in the solubilization of 62% of the 
synaptosomal proteins. A S-6-fold increase in total 
adenylate cyclase activity was observed under condi- 
tions where 95% of the enzyme activity was solubilized 
(table 2, data concerning fraction 1 U). The specific 
activity of the soluble enzyme was g-fold higher than 
that of the particulate enzyme. These results are in 
accordance with those in [23] where solubilization 
was first shown to greatly increase brain adenylate 
cyclase specific activity. Exposure to 0.75% Lubrol 
of aldehyde-treated synaptosomes obulized proteins 
to an extent that varied inversely with the aldehyde 
Table 1 
Effects of aldehyde-treatment on the regulation of particulate adenylate cyclase by various effecters 
Synaptosomes Basal enzyme Ca’+ Ca’+ 2’-deoxyadenosine NaF CPP(NH)P 
spec. act. - 10mM 0.1 mM 
0.1 mM 1 mM 10nM 1mM 
Untreated 528 f 160 X0.63 x0.14 x0.5 x0.16 x2.1 x 1.5 
(r0.08) (kO.03) (+O.l) (kO.05) (kO.3) (+0.2) 
Glutaraldehyde- 686 + 30 X0.62 x0.20 x0.5 X0.25 x0.7 x0.9 
treated (0.5 mM) (kO.1) (?0.05) (kO.2) (20.1) (kO.05) (YkO.05) 
Cerebellar synaptosomes were suspended in cacodylate buffer, with or without 0.5 mM glutaraldehyde, 
for 10 min at 20°C. They were diluted in cold buffer and pelleted. The pellets suspended in 50 mM 
TrisHCl (pH 8.1) buffer, 5 mM Mg’+, were assayed for adenylate cyclase at 36°C. The aliquots assayed 
in the presence of NaF or Gpp(NH)p were preincubated with the effector for 20 min at 36°C. Basal 
adenylate cyclase activities (measured in 8 expt) are given in pmol CAMP. mg-’ . mm-‘. The effects of 
various enzyme effecters are expressed with respect to the corresponding enzyme basal activity, taken 
for 1 
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Table 2 
Effects of pre-exposure to NaF and/or glutaraldehyde-treatment of synaptosomes on the solubiliied adenylate cyclase 
Fractions Particulate 
enzyme 
(spec. act.) 
Increase in enzyme 
activity caused by 
Lubrol (-fold) 
Proteins 
solubilized 
by Lubrol (%) 
Enzyme 
solubilized 
by Lubrol (%) 
Soluble enzyme 
(spec. act.) 
Preincubation Ul 
I without NaF Al 
Preincubation \ U2 
with NaF 1A2 
317 + 122 5.55 c 0.45 62.5 f 3.5 93.3 f 3.5 1810 f 110 
316 f 169 5.45 f 0.35 31.5 + 0.5 60.5 * 0.5 2870 * 93 
475 f 63 5.5 ? 0.3 61.5 ? 6.5 92 +_2 2832~ 70 
570 + 80 5.5 * 0.4 33.5 * 2.5 63 +8 4917 + 143 
Cerebellar synaptosomes were incubated at 30°C for 30 min in cacodylate buffer, with (fraction 2) or without 20 mM NaF (frac- 
tion 1). Each fraction was divided into 2 aliquots, one of which was treated with 1 mM glutaraldehyde for 10 min at 20°C, (frac- 
tions A) and the other was not treated (fractions U). The fractions were diluted and pelleted. The pellets, resuspended in 50 mM 
TrissHCl buffer (pH 8.1), 5 mM Mg*, were assayed for adenylate cyclase activity at 30°C. The enzyme basal specific activities 
(spec. act.), expressed in pmol. mg-’ m&r, are given in the first column (mean of 3 expt). Aliquots were homogenized by hand 
in 50 mM Tris-HCl buffer (pH 8.1) containing 2 mM DTT and 0.75% Lubrol-PX (Lubrol : protein ratio, 9 f 2). The adenylate 
cyclase activities of the unfractionated Lubrol suspensions, and of the supernatants and pellets obtained by centrifugation at 
40 000 X g for 10 mm, were measured at 30°C in the presence of 5 mM Mg*+. The increase in enzyme activity caused by Lubrol 
treatment is given with respect to the particulate enzyme activity, taken for 1. (The differences in adenylate cyclase specific 
activities, between table 1 and table 2, are due to the differences in the temperature of the assays, and to the 30 min preincuba- 
tion at 30°C in the case of table 2) 
concentration. The increase in total adenylate cyclase 
activity caused by Lubrol also depended on the alde- 
hyde concentration. At low glutaraldehyde concentra- 
tion (GO.5 mM), 60% of the enzyme activity was solu- 
bilized, and its specific activity was 9-fold that of the 
particulate enzyme (table 2, data concerning fraction 
1 A). At higher glutaraldehyde concentrations, the 
amount and specific activity of the soluble enzyme 
decreased (not shown). Adenylate cyclase solubility 
was however less affected than that of average mem- 
brane proteins. 
3.4.2. Properties of aldehyde-treated soluble adenylate 
cyclase 
For convenience, the adenylate cyclase solubilized 
from aldehyde-treated synaptosomes (fractions A) and 
from untreated synaptosomes (fractions U) will be 
referred to as aldehyde-treated and untreated soluble 
adenylate cyclases. The affinity of the aldehyde- 
treated enzyme for ATP appeared to be significantly 
higher than that of the untreated enzyme; however 
proper Km values could not yet be determined safely 
because of the interference of an ATPase at low ATP 
concentrations (in preparation). 
In contrast with the untreated particulate enzyme, 
the untreated soluble enzyme.was slightly inhibited 
by NaF (20-30%), as already shown [23]. NaF also 
inhibited the aldehyde-treated soluble enzyme. GTP 
and Gpp(NH)p slightly activated the untreated soluble 
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enzyme (O-20%) whereas they slightly inhibited the 
aldehyde-treated soluble enzyme. Solubilization did 
not alter the effects of EGTA (fig.3b), Ca2+ and 
adenosine (or its analogs) on aldehyde-treated or 
untreated enzymes. 
3 S. Effects of synaptosomes exposure to NaF or 
Gpp(NH)p prior to aldehyde treatment 
In the previous sections, we considered the situa- 
tion where the regulation of adenylate cyclase was 
studied after treatment of the synaptosomes by alde- 
hyde. Here we report on the effects of aldehyde treat- 
ment upon the adenylate cyclase activity of synapto- 
somes pre-exposed to Gpp(NH)p or NaF. 
As expected for NaF activation, which is known to 
withstand washing of the fractions [24], the adenylate 
cyclase activities of washed fractions were higher if 
they had been preincubated with NaF (table 2, frac- 
tion 2 U) than in the absence of NaF (table 2, frac- 
tion 1 U). Similarly, the adenylate cyclase activities 
from fractions treated with aldehydes were higher if 
they had been preincubated with NaF (table 2, frac- 
tion 2 A) than without NaF (table 2, fraction 1 A). 
As expected for Gpp(NH)p activation [24], the same 
results were found in the case of fractions preincubated 
with Gpp(NH)p. Once established, the activated state 
of the enzyme was thus maintained by aldehyde treat- 
ment. Contrarily to adenylate cyclase activation by 
NaF or Gpp(NH)p which was not affected by washes 
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and/or aldehyde treatment, inhibition of adenylate 
cyclase by 2’-deoxyadenosine did not persist after 
washes or exposure to aldehydes. 
The adenylate cyclases from fractions preincubated 
with NaF or Gpp(NH)p, and either washed, or alde- 
hyde-treated, could no longer be ‘super’activated with 
NaF or Gpp(NH)p, but were still susceptible to inhibi- 
tion by Ca* or by adenosine or its analogs. 
Initial exposure of synaptosomes to NaF did not 
modify the extent of protein or adenylate cyclase 
solubilization by Lubrol with respect to that found 
in the fraction incubated without NaF (table 2, com- 
pare fractions 1 U and 2 U, and fractions 1 A and 
2 A). Adenylate cyclase solubilized from fractions 
preincubated with NaF had much higher specific 
activities than those solubilized from fractions pre- 
incubated in the absence of NaF (table 2, compare 
fractions 1 U and 2 U, and fractions 1 A and 2 A). 
Once established the activation of the enzyme was 
thus maintained in the soluble state, regardless of 
the aldehyde treatment. 
4. Discussion 
Treatment of cerebellar synaptosomes by low alde- 
hyde concentrations preserved the particulate and 
soluble adenylate cyclase basal activity and resulted 
in the complete loss of activation of particulate enzyme 
by GTP, Gpp(NH)p or NaF. Other compounds, such 
as filipin, have been reported to abolish the enzyme 
stimulation by GTP or Gpp(NH)p but not by NaF 
[26]. Aldehydes also caused the loss of enzyme 
inhibition by EGTA, although this phenomenon 
appeared at higher aldehyde concentration than that 
observed for the loss of enzyme stimulation by 
Gpp(NH)p or NaF. 
In contrast with this loss of enzyme regulation, no 
change in adenylate cyclase inhibition by Ca’-, ade- 
nosine and its analogs could be observed under the 
influence of aldehyde treatment. 
Our results lead to the distinction of at least two 
categories of sites, or structures within the adenylate 
cyclase complex: (i) those which are not affected by 
aldehydes and may be closely related to the catalytic 
site (Ca” site, adenosine site or sites); (ii) those which 
are affected by aldehyde treatment and become func- 
tionally uncoupled from the catalytic site. The loss of 
adenylate cyclase regulation by GTP, Gpp(NH)p, NaF 
and EGTA strongly resembles the ‘desensitization’ 
described in the case of allosteric enzymes [27]. As a 
consequence of the aldehyde treatment, the function 
of the regulatory subunits responding to Gpp(NH)p 
and to NaF, and/or their association with the cata- 
lytic subunit, could be altered. Several possibilities 
should be explored. 
(1) We do not yet know the effects of aldehyde treat- 
ment upon the adenylate cyclase associated 
GTPase [28]. 
(2) The catalytic site of the enzyme could be modi- 
fied in such a way as to prevent any subsequent 
conformational change. If activation of the 
enzyme by Gpp(NH)p or NaF takes place after 
aldehyde treatment, then the conformational 
change of the catalytic subunit normally asso- 
ciated with ligand binding and resulting in acti- 
vation would be prevented. If activation of the 
enzyme by Gpp(NH)p or NaF takes place before 
aldehyde treatment, then the conformational 
charge in the catalytic subunit induced by the 
ligand and leading to the activated state would 
be permanently preserved, although any sub- 
sequent heterotropic regulation by NaF, 
Gpp(NH)p or eventually EGTA would be abol- 
ished. Indeed, aldehydes have been shown to 
fix the active conformation of allosteric enzymes 
in the crystalline [29] or in the soluble state [18]. 
Other crosslinking agents also stabilize conforma- 
tional states of purified enzymes [30,3 11. 
(3) The state of association of components of the 
adenylate cyclase complex prevailing at the time 
of aldehyde treatment could be stabilized by this 
treatment. A rather large set of data is in favour 
of a parallel increase in solubilized adenylate 
cyclase catalytic activity and molecular weight 
[5,32,33], possibly due to a close association of 
the enzyme catalytic subunit with the guanine- 
nucleotide binding protein and/or other struc- 
tures. Discrepant data have been reported 
however some of them favouring the concept of 
adenylate cyclase being most active when existing 
as a fully dissociated catalytic subunit [34,35]. 
Finally, in the case of adenylate cyelase regula- 
tion by EGTA, the possibility should also be 
explored that Mn2+ would become permanently 
trapped inside the protein-EGTA is indeed 
thought to inhibit the brain enzyme by chelating 
Mn’+ [36]. 
Distinction between these alternatives must await 
further purification of the components of the ade- 
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nylate cyclase complex. In this respect, the use of 
chemical crosslinkers should open new possibilities. 
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